Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.

Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH

Open access

Abstract

Nonalcoholic steatohepatitis (NASH) is a manifestation of systemic metabolic disease related to obesity, and causes liver disease and cancer 1,2. The accumulation of metabolites leads to cell stress and inflammation in the liver 3, but mechanistic understandings of liver damage in NASH are incomplete. Here, using a preclinical mouse model that displays key features of human NASH (hereafter, NASH mice), we found an indispensable role for T cells in liver immunopathology. We detected the hepatic accumulation of CD8 T cells with phenotypes that combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics. Liver CXCR6+ CD8 T cells were characterized by low activity of the FOXO1 transcription factor, and were abundant in NASH mice and in patients with NASH. Mechanistically, IL-15 induced FOXO1 downregulation and CXCR6 upregulation, which together rendered liver-resident CXCR6+ CD8 T cells susceptible to metabolic stimuli (including acetate and extracellular ATP) and collectively triggered auto-aggression. CXCR6+ CD8 T cells from the livers of NASH mice or of patients with NASH had similar transcriptional signatures, and showed auto-aggressive killing of cells in an MHC-class-I-independent fashion after signalling through P2X7 purinergic receptors. This killing by auto-aggressive CD8 T cells fundamentally differed from that by antigen-specific cells, which mechanistically distinguishes auto-aggressive and protective T cell immunity.

Overview

CoChat Summary

## TL;DR

This paper argues that liver-resident CXCR6+ CD8 T cells are a key driver of liver immunopathology in NASH. In a mouse NASH model and in patients with NASH, these cells showed a CXCR6/granzyme/PD1 phenotype, low FOXO1 activity, and auto-aggressive killing linked to IL-15, metabolic stimuli, and P2X7 signaling.

## Key findings

  • Using a preclinical mouse model that displayed key features of human NASH, the authors found an “indispensable role” for T cells in liver immunopathology.
  • They detected hepatic CD8 T cells combining tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics.
  • CXCR6+ CD8 T cells had low FOXO1 activity and were abundant both in NASH mice and in patients with NASH.
  • Mechanistically, IL-15 induced FOXO1 downregulation and CXCR6 upregulation; together with metabolic stimuli such as acetate and extracellular ATP, this triggered auto-aggression and MHC-class-I-independent killing through P2X7 purinergic receptors.

## Methods

  • Preclinical mouse model of NASH with “key features of human NASH”; the paper also compared findings with patients with NASH.
  • The analysis focused on hepatic CD8 T cells, assessing phenotype, FOXO1 activity, transcriptional signatures, and killing behavior.
  • Main mechanistic tests examined the effects of IL-15 and metabolic stimuli (including acetate and extracellular ATP), and implicated P2X7 signaling in auto-aggressive killing.

## Limitations

  • The paper states that mechanistic understandings of liver damage in NASH are incomplete; this is the knowledge gap motivating the study.
  • The text provided does not state specific numerical sample sizes, effect sizes, or cohort characteristics for the mouse model or patient analyses.
  • Evident from the text: the core mechanistic claims are based on a preclinical mouse model plus observations in patients with NASH, so the extent of causal inference in humans is not fully established in the provided text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41586-021-03233-8

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 0 Not checked · 12 Own results and interpretations

3 more claims

Create a free account to see all 12 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 3
  • Probably not a substantial claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 59 references

Cited by

See all 518

Metadata

Authors
Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., Inverso, D., Wigger, J., Sebode, M., Öllinger, R., Rad, R., Hegenbarth, S., Anton, M., Guillot, A., Bowman, A., Heide, D., Müller, F., Ramadori, P., Leone, V., Garcia-Caceres, C., Gruber, T., Seifert, G., Kabat, A. M., Mallm, J.-P., Reider, S., Effenberger, M., Roth, S., Billeter, A. T., Müller-Stich, B., Pearce, E. J., Koch-Nolte, F., Käser, R., Tilg, H., Thimme, R., Boettler, T., Tacke, F., Dufour, J.-F., Haller, D., Murray, P. J., Heeren, R., Zehn, D., Böttcher, J. P., Heikenwälder, M., & Knolle, P. A.
Affiliations
  • Technical University of Munich (DE)
  • German Cancer Research Center (DE)
  • German Center for Infection Research (DE)
  • University Medical Center Hamburg-Eppendorf (DE)
  • TUM Klinikum (DE)
  • Charité – Universitätsmedizin Berlin (DE)
  • Maastricht University (NL)
  • Helmholtz Munich (DE)
  • University of Freiburg (DE)
  • Max Planck Institute of Immunobiology and Epigenetics (DE)
  • Innsbruck Medical University (AT)
  • Heidelberg University (DE)
  • Max Planck Institute of Biochemistry (DE)
Corresponding author
Knolle, Percy A.
Venue
Nature
Published
2021-03-24
Volume
592
Issue
7854
Pages
444-449
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3139423362
Cited by
518
References
59
Citations by year
2026: 88 · 2025: 101 · 2024: 111 · 2023: 106 · 2022: 70 · 2021: 40
FWCI
38.50
Type
journal article
Language
en
Licence
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Site cant be reached (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
Tehran University of Medical Sciences and Health Services
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
nonalcoholic steatohepatitis, T cell exhaustion, FOXO1, IL-15, extracellular ATP, acetate, T cell metabolism, liver inflammation
MeSH terms
Receptors, CXCR6, Acetates, Animals, Disease Models, Animal, Humans, Liver, Male, Mice, Inbred C57BL, Cell Death, CD8-Positive T-Lymphocytes, Interleukin-15, Mice, Diet, High-Fat, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. https://app.cochat.ai/papers/10.1038/s41586-021-03233-8
The paper
Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., Inverso, D., Wigger, J., Sebode, M., Öllinger, R., Rad, R., Hegenbarth, S., Anton, M., Guillot, A., Bowman, A., . . . Knolle, P. A. (2021). Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. Nature. https://doi.org/10.1038/s41586-021-03233-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.